Stay updated on Halodine Nasal Antiseptic in Patients With COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Halodine Nasal Antiseptic in Patients With COVID-19 Clinical Trial page.

Latest updates to the Halodine Nasal Antiseptic in Patients With COVID-19 Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe ClinicalTrials.gov record for a Phase 4 study of Halodine nasal antiseptic in hospitalized patients with COVID-19 is displayed, including its study plan, participant criteria, contacts, and record history.SummaryDifference38%

- Check17 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedA new NIH notice announces a terminology transition from “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434 and links to updates and FAQs.SummaryDifference1%

- Check31 days agoChange DetectedThe footer’s site revision label updates from v3.7.1 to v3.7.2, while the page continues to display a 403 error.SummaryDifference0.2%

- Check38 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check59 days agoChange DetectedThe page now presents a 403 Forbidden error with a minimal header, replacing the detailed study record content. This reflects an access/visibility issue rather than an update to the study data.SummaryDifference16%

Stay in the know with updates to Halodine Nasal Antiseptic in Patients With COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Halodine Nasal Antiseptic in Patients With COVID-19 Clinical Trial page.